ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

ORI Final Findings Of Scientific Misconduct

September 16, 1994

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.

February 25, 2000

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003